Mehmet SOLAKHAN, Ömer BAYRAK, İlker SEÇKİNER, Haluk ŞEN, Hanifi ÖZGÜL, Sakıp ERTUHAN

Priapizm olgularında terbutalin kullanımının etkinliği

Priapizm olgularında erken ve geç dönemde oral terbutalin kullanımının etkinliğinin ortaya konması amaçlandı. İntrakavernozal vazoaktif ilaç injeksiyonu sonrası priapism gelişen, yaş aralığı 28-56 (ortalama 38,4) yıl olan 73 hastaya ait sonuçlar retrospektif olarak incelendi. Hastalar intrakavernozal enjeksiyondan sonra ilk 8 saatte başvuranlar (Grup 1, n=25), 8-16. saatler arasında başvuranlar (Grup 2, n=29) ve daha sonra başvuranlar (Grup 3, n=19) olarak üç gruba ayrıldı. Tüm hastalara terbutaline 5 mg oral olarak verildi ve 1 saatlik bekleme süresini takiben sonuçlar değerlendirildi. Grup 1, 2 ve 3’deki hastalarda sırasıyla 14 (%56), 10 (%34.4) ve 1 (%5.2) hastada oral terbutalin kullanımı sonrasında detümesans oluştu. Gruplar arasındaki farklar istatistiksel olarak anlamlı bulundu (p

The efficacy of oral terbutaline in cases with priapism

The aim of this study was to evaluate the efficacy of oral terbutaline in the treatment of cases with early and late periods of priapism. Results belonging to 73 patients between the age of 28 and 56 (mean age 38.4), with priapism secondary by intracavernous injection of vasoactive agents, were evaluated retrospectively. Patients were divided into three groups as: applicants in the first 8 h (Group 1, n=25), applicants between 8 and 16 h (Group 2, n=29), and applicants later than 16 h (Group 3, n=19). Ten miligrams of terbutaline was given orally to all patients and the outcomes were evaluated following a 1-h waiting period. After the oral administration of terbutaline, penile detumescence were obtained 14 (56%), 10 (34.4%), and 1 (5.2%) patients in groups 1, 2, and 3, respectively. The differences between the groups were found to be statistically significant (p

PDF

___

1. Wasmer JM, Carrion HM, Mekras G, Politano VA. Evaluation and treatment of priapism. J Urol 1981;125:204-7.
2. Van der Horst C, Stuebinger H, Seif C, Melchior D, Martínez- Portillo FJ, Juenemann KP. Priapism-etiology, pathophysiology and management. Int Braz J Urol 2003;29(5):391-400.
3. Keoghane SR, Sullivan ME, Miller MA. The aetiology, pathogenesis and management of priapism. BJU Int 2002;90(2):149-54.
4. Ciampalini S, Savoca G, Buttazzi L, Gattuccio I, Mucelli FP, Bertolotto M, et al. High-flow priapism: Treatment and longterm follow-up. Urology 2002;59(1):110-3.
5. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986;135:142-7.
6. Domer FR, Wessler G, Brown RL, Charles HC. Involvement of the sympathetic nervous system in the urinary bladder internal sphincter and in penile erection in the anesthetized cat. Invest Urol 1978;15(5):404-7.
7. Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989;141(6):1427-9.
8. Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol 1994;151(4):878-9.
9. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology 1993;42(1):51-3.
10. Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res 2004;16(5):424-6.
11. Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology 2001;57(5):970-2.
12. Kulmala RV, Lehtonen TA, Tammela TL. Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol 1995;29:93-6.
13. Pautler SE, Brock GB. Priapism. From priapus to the present time. Urol Clin North Am 2001;28(2):391-403.
14. Rösener M, Wechsel HW, Dichgans J. Intrazerebrale Massenblutung nach intrakavernöser Metaraminol-Behandlung einer prolongierten erektion. Akt Urol 1995;26:427-30.
15. Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol 1996;155(1):141-3.
16. Dittrich A, Albrecht K, Bar-Moshe O, Vandendris M. Treatment of pharmacological priapism with phenylephrine. J Urol 1991;146(2):323-4.
17. Martinez Portillo FJ, Fernandez Arancibia MI, Bach S, Alken P, Junemann KP. Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents. Arch Esp Urol 2002;55(3):303-8.
18. Hubler J, Szanto A, Konyves K. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol 2003;35(4):519-21.
19. Teyah A, Rahman El-Nashar A, Zohdy W, Arafa M, Saad El-Den H. Intracavernosal irrigation by cold saline as a simple method of treating iatrogenic prolonged erection. J Sex Med 2005;2(2):248-53.
20. Soni BM, Vaidyanathan S, Krishan KR. Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics. Paraplegia 1994;32:670-4.